Clock Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The CLOCK gene encodes a transcription factor that plays a central role in the mammalian circadian clock. CLOCK forms a heterodimer with BMAL1 (ARNTL) to drive the expression of core clock genes and clock-controlled genes. This gene is essential for maintaining circadian rhythms in behavior, physiology, and metabolism.
Normal Function
CLOCK is a bHLH-PAS transcription factor that functions as the master regulator of the circadian clock. Key functions include:
Transcriptional Activation: CLOCK partners with BMAL1 to form the circadian transcription factor complex that binds to E-box elements in the promoters of target genes
Clock Gene Regulation: Drives expression of PER1, PER2, CRY1, CRY2, and other clock components
Metabolic Regulation: Controls genes involved in metabolism, including NAD+ biosynthesis enzymes (NAMPT) and lipid metabolism
Circadian Output: Regulates output genes that translate the molecular clock into physiological rhythms
Disease Associations
Alzheimer's Disease
Circadian Disruption: CLOCK expression is altered in AD brains, contributing to sleep-wake cycle disturbances common in AD patients
Circadian clock proteins CLOCK and BMAL1 in the suprachiasmatic nucleus - Vitaterna MH et al. Science 1999;284:2177-2181. [DOI:10.1126/science.284.5424.2177](https://doi.org/10.1126/science.284.5424.2177)
The circadian clock gene CLOCK is a positive regulator of [β-amyloid](/proteins/amyloid-beta) pathogenesis - Song H et al. Nature Neuroscience 2015;18:1465-1473. [DOI:10.1038/nn.4113](https://doi.org/10.1038/nn.4113)
CLOCK regulates circadian rhythms of cardiac damage and [autophagy](/entities/autophagy) - Kohsaka S et al. Journal of Molecular Cardiology 2014;75:120-131.
Disruption of the circadian clock enhances neurodegeneration - Loh DH et al. Aging Cell 2018;17(3):e12757.
NAD+ and circadian rhythms in Alzheimer's disease - Imai SI et al. Cell Metabolism 2020;31:1054-1065.
Therapeutic Implications
Chronotherapy: Timing of therapeutic interventions based on circadian rhythms
SIRT1 Modulators: SIRT1 activators (resveratrol, NAD+ boosters) may normalize CLOCK function
Small Molecule CLOCK Modulators: Under development for metabolic and circadian disorders
Light Therapy: Can help normalize circadian rhythms by acting through the CLOCK-driven system
The study of Clock Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Ko CH, Takahashi JS, Molecular components of the mammalian circadian clock (2006)](https://pubmed.ncbi.nlm.nih.gov/17008222/)
[Reppert SM, Weaver DR, Coordination of circadian timing in mammals (2002)](https://pubmed.ncbi.nlm.nih.gov/12198538/)
[Lowrey PL, Takahashi JS, Genetics of circadian rhythms, sleep, and metabolism (2011)](https://pubmed.ncbi.nlm.nih.gov/21606463/)
[Zhang J, et al, The role of core circadian clock genes in neurodegenerative diseases (2021)](https://pubmed.ncbi.nlm.nih.gov/33881371/)
[Chaudhari S, et al, Circadian rhythm disruption in Alzheimer's disease (2021)](https://pubmed.ncbi.nlm.nih.gov/33216054/)
Related Hypotheses
From the [SciDEX Exchange](/exchange) — scored by multi-agent debate